Bachem Holding AG
BANB
Classifica tra le azioni
#2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Prezzo delle azioni
$100.60
Capitalizzazione di mercato
$7.54B
Variazione (1 giorno)
-1.49%
Variazione (1 anno)
49.53%
Paese
CH
Scambia Bachem Holding AG (BANB)
Categoria
Healthcare
Ricavi di Bachem Holding AG (BANB)
Ricavi nel Oct 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Bachem Holding AG, i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Bachem Holding AG da 2002 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2025 | $875.88M | 30.72% |
| 2024 | $670.05M | -2.39% |
| 2023 | $686.47M | 19.36% |
| 2022 | $575.15M | 4.20% |
| 2021 | $551.97M | 23.34% |
| 2020 | $447.51M | 38.00% |
| 2019 | $324.29M | 12.93% |
| 2018 | $287.17M | 6.98% |
| 2017 | $268.42M | 15.53% |
| 2016 | $232.34M | 11.33% |
| 2015 | $208.69M | 12.70% |
| 2014 | $185.17M | -3.20% |
| 2013 | $191.29M | 11.30% |
| 2012 | $171.87M | 10.72% |
| 2011 | $155.22M | -5.12% |
| 2010 | $163.59M | -7.04% |
| 2009 | $175.99M | -3.60% |
| 2008 | $182.56M | 4.04% |
| 2007 | $175.47M | 24.55% |
| 2006 | $140.88M | 20.66% |
| 2005 | $116.75M | -10.21% |
| 2004 | $130.03M | 11.21% |
| 2003 | $116.92M | 7.90% |
| 2002 | $108.36M | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $12.62B | - |
US
|
|
| $2.23B | - |
US
|
|
| $15.74B | - |
AU
|
|
| $6.02B | - |
NL
|
|
| - | - |
CH
|
